Global Cancer Diagnostics Market - Forecasts From 2018 to 2023

  • ID: 4718388
  • Report
  • Region: Global
  • 110 pages
  • Knowledge Sourcing Intelligence LLP
1 of 4


  • Arquer Diagnostics Ltd
  • bioMérieux, Inc
  • Breath Diagnostics, Inc.
  • Cancer Genetics Inc.
  • Castle Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd
  • MORE
The global cancer diagnostics market is projected to grow at a CAGR of 14.22%, increasing from US$9.050 billion in 2017 to US$20.099 billion in 2023. As per data by WHO, cancer is the second leading cause of death globally with an estimated 9.6 million deaths in 2018, with the lung, colorectal, stomach, lever and breast cancer being the most common causes of cancer death. Cancer diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumour type, location, extent and stage. Correct diagnosis of the disease is important to develop an individualized cancer treatment plan. Cancer diagnostics market is expected to show a significant growth during the given forecast period. The rise in the market may be attributed to the rising prevalence of the disease coupled with the rising awareness among the people regarding the disease. Initiatives undertaken by governments and global health organizations to spread awareness about cancer will also boost the market during the given forecast period. However, high cost of diagnostic imaging systems along with the high capital investments might restrain the market for cancer diagnostics during the given forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global cancer diagnostics market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global cancer diagnostics market.

Major industry players profiled as part of the report are bioMérieux, Inc, Arquer Diagnostics Ltd and Castle Biosciences, Inc. among others.


By Diagnostic Procedures

Laboratory Tests
Imaging Procedures

By Application

Lung Cancer
Breast Cancer
Colorectal Cancer
Skin Cancer
Stomach Cancer
Other Cancers

By End Users

Hospitals and Clinics
Diagnostic Centres

By Geography

North America
United States

South America

United Kingdom

Middle East and Africa
Saudi Arabia

Asia Pacific
South Korea
Note: Product cover images may vary from those shown
2 of 4


  • Arquer Diagnostics Ltd
  • bioMérieux, Inc
  • Breath Diagnostics, Inc.
  • Cancer Genetics Inc.
  • Castle Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd
  • MORE
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. Key Findings of the Study

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. Global Cancer Diagnostics Market Forecast by Diagnostic Procedures
5.1. Laboratory Tests
5.2. Imaging Procedures
5.3. Biopsy

6. Global Cancer Diagnostics Market Forecast by Application
6.1. Lung Cancer
6.2. Breast Cancer
6.3. Colorectal Cancer
6.4. Skin Cancer
6.5. Stomach Cancer
6.6. Other Cancers

7. Global Cancer Diagnostics Market Forecast by End Users
7.1. Hospitals and Clinics
7.2. Diagnostic Centres

8. Global Cancer Diagnostics Market Forecast by Geography (US$ billion)
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others

9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. Company Profiles
10.1. bioMérieux, Inc
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. F. Hoffmann-La Roche Ltd
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Sienna Cancer Diagnostics
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. Insight Genetics
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. MetaCell
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Cancer Genetics Inc.
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Breath Diagnostics, Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Arquer Diagnostics Ltd
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Metabiomics
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Castle Biosciences, Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • bioMérieux, Inc
  • F. Hoffmann-La Roche Ltd
  • Sienna Cancer Diagnostics
  • Insight Genetics
  • MetaCell
  • Cancer Genetics Inc.
  • Breath Diagnostics, Inc.
  • Arquer Diagnostics Ltd
  • Metabiomics
  • Castle Biosciences, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: